AI filing briefs · archive

8-K filings in September 2025, explained

427 material Form 8-K filings that 376 companies we cover made with the SEC in September 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

2 of 427 briefs match

newest first · times in ET
SNPSSYNOPSYS INC Sep 9, 4:15 PM ET

Synopsys Q3 revenue rises 14% to $1.740 billion; GAAP earnings per share fall to $1.50

Mixed earnings Written later 2.02

Synopsys reported third-quarter fiscal 2025 revenue of $1.740 billion, up 14% from a year earlier, after closing the Ansys acquisition on July 17, 2025. GAAP net income fell to $242.5 million from $425.9 million, and the CEO said the IP business underperformed expectations, while the CFO said the company is taking a more conservative view of the fourth quarter.

  • Q3 GAAP earnings per diluted share were $1.50, versus $2.73 a year earlier; non-GAAP earnings per diluted share were $3.39, versus $3.43.
  • Design IP segment revenue was $427.6 million, down from $463.1 million, and its adjusted operating margin fell to 20.1% from 36.7%.
  • Full-year fiscal 2025 revenue target is $7.03 billion to $7.06 billion; fourth-quarter GAAP earnings per share target is a loss of $0.27 to $0.16.
  • Q3 interest expense was $146.5 million, compared with $11.7 million a year earlier.
Read the filing on SEC.gov ↗
CNMCore & Main, Inc. Sep 9, 7:30 AM ET

Core & Main Q2 sales rise 6.6% and profit grows, but full-year outlook is cut

Mixed guidance Written later 2.02

Core & Main reported fiscal second-quarter 2025 results for the period ended August 3, 2025, with net sales up 6.6% to $2,093 million and net income up 11.9% to $141 million. The company also lowered its full-year fiscal 2025 guidance, citing market conditions and higher operating expenses, which matters to shareholders because the revised outlook is below the earlier expectations.

  • Q2 net sales rose 6.6% to $2,093 million; diluted EPS rose 14.8% to $0.70
  • Q2 net income rose 11.9% to $141 million; Adjusted EBITDA rose 3.5% to $266 million
  • Full-year net sales guidance lowered to $7,600 to $7,700 million; Adjusted EBITDA to $920 to $940 million
  • Full-year operating cash flow guidance set at $550 to $610 million; Q2 operating cash flow was $34 million
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.